| Year |
Citation |
Score |
| 2024 |
Song G, Sun Z, Chu M, Zhang Z, Chen J, Wang Z, Zhu X. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer. Bmc Cancer. 24: 122. PMID 38267923 DOI: 10.1186/s12885-024-11893-8 |
0.345 |
|
| 2024 |
Chen K, Wang Y, Dai X, Luo J, Hu S, Zhou Z, Shi J, Pan X, Cao T, Xia J, Li Y, Wang Z, Ma J. FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Cell Death & Disease. 15: 37. PMID 38216561 DOI: 10.1038/s41419-024-06425-y |
0.338 |
|
| 2024 |
Liu J, Li S, Wang Q, Feng Y, Xing H, Yang X, Guo Y, Guo Y, Sun H, Liu X, Yang S, Mei Z, Zhu Y, Cheng Z, Chen S, ... ... Wang Z, et al. Sonrotoclax overcomes BCL2 G101V mutation-induced venetoclax resistance in preclinical models of hematologic malignancy. Blood. PMID 38211332 DOI: 10.1182/blood.2023019706 |
0.301 |
|
| 2024 |
Yao X, Mao Y, Wu D, Zhu Y, Lu J, Huang Y, Guo Y, Wang Z, Zhu S, Li X, Lu Y. Corrigendum to "Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis" [Cancer Lett. 512 (2021) 38-50]. Cancer Letters. 216603. PMID 38169237 DOI: 10.1016/j.canlet.2023.216603 |
0.355 |
|
| 2023 |
Liu Y, Liu H, Ye M, Jiang M, Chen X, Song G, Ji H, Wang ZW, Zhu X. Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion. Cell Death & Disease. 14: 624. PMID 37737256 DOI: 10.1038/s41419-023-06149-5 |
0.339 |
|
| 2023 |
Chu M, Ji H, Li K, Liu H, Peng M, Wang Z, Zhu X. Investigating the potential mechanism of quercetin against cervical cancer. Discover. Oncology. 14: 170. PMID 37704909 DOI: 10.1007/s12672-023-00788-y |
0.325 |
|
| 2023 |
Wang Z, Chen F, Wang Y, Gou S. Blockade of chemo-resistance to 5-FU by a CK2-targeted combination via attenuating AhR-TLS-promoted genomic instability in human colon cancer cells. Toxicology and Applied Pharmacology. 475: 116647. PMID 37543059 DOI: 10.1016/j.taap.2023.116647 |
0.353 |
|
| 2023 |
Yang C, Ge Y, Zang Y, Xu M, Jin L, Wang Y, Xu X, Xue B, Wang Z, Wang L. CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression. Apoptosis : An International Journal On Programmed Cell Death. PMID 37535214 DOI: 10.1007/s10495-023-01877-7 |
0.404 |
|
| 2022 |
Yang C, Xiang H, Fu K, Jin L, Yuan F, Xue B, Wang Z, Wang L. Lycorine suppresses cell growth and invasion via down-regulation of NEDD4 ligase in bladder cancer. American Journal of Cancer Research. 12: 4708-4720. PMID 36381314 |
0.484 |
|
| 2022 |
Liu T, Cheng S, Xu Q, Wang Z. Management of Advanced Pancreatic Cancer through Stromal Depletion and Immune Modulation. Medicina (Kaunas, Lithuania). 58. PMID 36143975 DOI: 10.3390/medicina58091298 |
0.375 |
|
| 2022 |
Wang Q, Wu L, Cao R, Gao J, Chai D, Qin Y, Ma L, Wu S, Tao Y, Ma J, Wang ZW. Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation. Oncogene. PMID 36127399 DOI: 10.1038/s41388-022-02468-7 |
0.334 |
|
| 2022 |
Lin M, Zhang J, Bouamar H, Wang Z, Sun LZ, Zhu X. Fbxo22 promotes cervical cancer progression via targeting p57 for ubiquitination and degradation. Cell Death & Disease. 13: 805. PMID 36127346 DOI: 10.1038/s41419-022-05248-z |
0.309 |
|
| 2022 |
Cao T, Cui Y, Wang Y, Wu L, Yu K, Chen K, Xia J, Li Y, Wang ZP, Ma J. CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma. Apoptosis : An International Journal On Programmed Cell Death. PMID 36038736 DOI: 10.1007/s10495-022-01764-7 |
0.378 |
|
| 2022 |
Song Y, Li R, Ye M, Pan C, Zheng L, Wang ZW, Zhu X. Differences in chemotaxis of human mesenchymal stem cells and cervical cancer cells. Apoptosis : An International Journal On Programmed Cell Death. PMID 35849265 DOI: 10.1007/s10495-022-01749-6 |
0.339 |
|
| 2022 |
Luo H, Song Y, Zhang JA, Liu Y, Chen F, Wang Z, Zhu X. MAT2A facilitates PDCD6 methylation and promotes cell growth under glucose deprivation in cervical cancer. Cell Death Discovery. 8: 176. PMID 35396512 DOI: 10.1038/s41420-022-00987-6 |
0.341 |
|
| 2022 |
Zheng C, Chu M, Chen Q, Chen C, Wang ZW, Chen X. The role of lncRNA OIP5-AS1 in cancer development and progression. Apoptosis : An International Journal On Programmed Cell Death. PMID 35316453 DOI: 10.1007/s10495-022-01722-3 |
0.431 |
|
| 2022 |
Wu L, Yu K, Chen K, Zhu X, Yang Z, Wang Q, Gao J, Wang Y, Cao T, Xu H, Pan X, Wang L, Xia J, Li Y, Wang ZP, et al. Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation. Cell Death & Disease. 13: 231. PMID 35279684 DOI: 10.1038/s41419-022-04675-2 |
0.387 |
|
| 2022 |
Chen Z, He L, Zhao L, Zhang G, Wang Z, Zhu P, Liu B. circREEP3 Drives Colorectal Cancer Progression via Activation of FKBP10 Transcription and Restriction of Antitumor Immunity. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2105160. PMID 35233964 DOI: 10.1002/advs.202105160 |
0.302 |
|
| 2022 |
Ye M, Wang J, Pan S, Zheng L, Wang ZW, Zhu X. Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers. Molecular Therapy Oncolytics. 24: 101-113. PMID 35024437 DOI: 10.1016/j.omto.2021.12.005 |
0.308 |
|
| 2021 |
Xie S, Xia L, Song Y, Liu H, Wang ZW, Zhu X. Insights Into the Biological Role of NEDD4L E3 Ubiquitin Ligase in Human Cancers. Frontiers in Oncology. 11: 774648. PMID 34869021 DOI: 10.3389/fonc.2021.774648 |
0.392 |
|
| 2021 |
Xu Y, Chen X, Pan S, Wang ZW, Zhu X. TM7SF2 regulates cell proliferation and apoptosis by activation of C-Raf/ERK pathway in cervical cancer. Cell Death Discovery. 7: 299. PMID 34667152 DOI: 10.1038/s41420-021-00689-5 |
0.443 |
|
| 2021 |
Ye M, Lin Y, Pan S, Wang ZW, Zhu X. Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis. Frontiers in Oncology. 11: 745808. PMID 34631583 DOI: 10.3389/fonc.2021.745808 |
0.312 |
|
| 2021 |
Wang Z, Li M, Liu Y, Qiao Z, Bai T, Yang L, Liu B. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression. Oncology Reports. 46. PMID 34558645 DOI: 10.3892/or.2021.8191 |
0.306 |
|
| 2021 |
Nong S, Wang Z, Wei Z, Ma L, Guan Y, Ni J. HN1L promotes stem cell-like properties by regulating TGF-β signaling pathway through targeting FOXP2 in prostate cancer. Cell Biology International. PMID 34519127 DOI: 10.1002/cbin.11701 |
0.36 |
|
| 2021 |
Li R, Song Y, Chen X, Chu M, Wang ZW, Zhu X. METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE. Molecular Therapy Oncolytics. 22: 245-255. PMID 34514103 DOI: 10.1016/j.omto.2021.05.013 |
0.424 |
|
| 2021 |
Nong S, Wei Z, Wang Z, Ma L, Guan Y, Ni J. Reduced DAPK1 expression promotes stem cell-like characteristics of prostate cancer cells by activating ZEB1via Hippo/YAP signaling pathway. Stem Cells and Development. PMID 34289746 DOI: 10.1089/scd.2021.0043 |
0.336 |
|
| 2021 |
Chu M, Zheng C, Chen C, Song G, Hu X, Wang ZW. Targeting cancer stem cells by nutraceuticals for cancer therapy. Seminars in Cancer Biology. PMID 34273521 DOI: 10.1016/j.semcancer.2021.07.008 |
0.41 |
|
| 2021 |
Hu X, Yu J, Lin Z, Feng R, Wang ZW, Chen G. The emerging role of WWP1 in cancer development and progression. Cell Death Discovery. 7: 163. PMID 34226507 DOI: 10.1038/s41420-021-00532-x |
0.397 |
|
| 2021 |
Li G, Wang Z, Fei X, Li J, Zheng Y, Li B, Zhang T. Identification and elimination of cancer cells by folate-conjugated CdTe/CdS Quantum Dots Chiral Nano-Sensors. Biochemical and Biophysical Research Communications. 560: 199-204. PMID 34000469 DOI: 10.1016/j.bbrc.2021.04.068 |
0.305 |
|
| 2021 |
Yao X, Mao Y, Wu D, Zhu Y, Lu J, Huang Y, Guo Y, Wang Z, Zhu S, Li X, Lu Y. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis. Cancer Letters. PMID 33971282 DOI: 10.1016/j.canlet.2021.04.030 |
0.313 |
|
| 2021 |
Xu Y, Pan S, Chen H, Qian H, Wang Z, Zhu X. MEX3A suppresses proliferation and EMT via inhibiting Akt signaling pathway in cervical cancer. American Journal of Cancer Research. 11: 1446-1462. PMID 33948367 |
0.444 |
|
| 2021 |
Li S, He P, Wang Z, Liang M, Liao W, Huang Y, Chi M, Liu F, Zen N, Su R, Chen S, Liu Z, Hong H. RNAi-mediated knockdown of PFK1 decreases the invasive capability and metastasis of nasopharyngeal carcinoma cell line, CNE-2. Cell Cycle (Georgetown, Tex.). 1-12. PMID 33404290 DOI: 10.1080/15384101.2020.1866279 |
0.331 |
|
| 2020 |
Wang L, Gao P, Yuan P, Zhou P, Fan H, Lin X, Yuan X, Zhu M, Fan X, Lu Y, Wang Z. miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]. PMID 33320287 DOI: 10.1007/s00066-020-01728-3 |
0.326 |
|
| 2020 |
Wang L, Yang C, Chu M, Wang ZW, Xue B. Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation. Cancer Letters. PMID 33290869 DOI: 10.1016/j.canlet.2020.11.052 |
0.403 |
|
| 2020 |
Xie W, Chu M, Song G, Zuo Z, Han Z, Chen C, Li Y, Wang ZW. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. Seminars in Cancer Biology. PMID 33207266 DOI: 10.1016/j.semcancer.2020.11.004 |
0.365 |
|
| 2020 |
Sheng B, Song Y, Zhang J, Li R, Wang Z, Zhu X. Atorvastatin suppresses the progression of cervical cancer via regulation of autophagy. American Journal of Translational Research. 12: 5252-5268. PMID 33042417 |
0.434 |
|
| 2020 |
Lin M, Wang ZW, Zhu X. FBXO45 is a potential therapeutic target for cancer therapy. Cell Death Discovery. 6: 55. PMID 32655893 DOI: 10.1038/s41420-020-0291-2 |
0.335 |
|
| 2020 |
Wang L, Lin M, Chu M, Liu Y, Ma J, He Y, Wang ZW. SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression. Ebiomedicine. 56: 102795. PMID 32460168 DOI: 10.1016/j.ebiom.2020.102795 |
0.338 |
|
| 2020 |
Wang Z, Song Y, Ye M, Dai X, Zhu X, Wei W. The diverse roles of SPOP in prostate cancer and kidney cancer. Nature Reviews. Urology. PMID 32355326 DOI: 10.1038/S41585-020-0314-Z |
0.351 |
|
| 2020 |
Tian W, Wang ZW, Yuan BM, Bao YG. Calycosin induces apoptosis in osteosarcoma cell line via ERβ‑mediated PI3K/Akt signaling pathways. Molecular Medicine Reports. PMID 32236598 DOI: 10.3892/mmr.2020.11039 |
0.329 |
|
| 2020 |
Wang ZW, Hu X, Ye M, Lin M, Chu M, Shen X. NEDD4 E3 ligase: Functions and mechanism in human cancer. Seminars in Cancer Biology. PMID 32171886 DOI: 10.1016/J.Semcancer.2020.03.006 |
0.496 |
|
| 2020 |
Zheng N, Chu M, Lin M, He Y, Wang Z. USP7 stabilizes EZH2 and enhances cancer malignant progression. American Journal of Cancer Research. 10: 299-313. PMID 32064169 |
0.476 |
|
| 2020 |
Song Y, Liu Y, Pan S, Xie S, Wang ZW, Zhu X. Role of the COP1 protein in cancer development and therapy. Seminars in Cancer Biology. PMID 32027978 DOI: 10.1016/J.Semcancer.2020.02.001 |
0.444 |
|
| 2020 |
Xu Y, Zou R, Wang J, Wang ZW, Zhu X. The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer. Cell Proliferation. e12770. PMID 32022332 DOI: 10.1111/cpr.12770 |
0.385 |
|
| 2020 |
Song Y, Xu Y, Pan C, Yan L, Wang ZW, Zhu X. The emerging role of SPOP protein in tumorigenesis and cancer therapy. Molecular Cancer. 19: 2. PMID 31901237 DOI: 10.1186/s12943-019-1124-x |
0.363 |
|
| 2019 |
Li ZT, Zhang X, Wang DW, Xu J, Kou KJ, Wang ZW, Yong G, Sun XY, Liang DS. Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/β-Catenin Signaling Pathway in GC. Molecular Therapy. Nucleic Acids. 19: 827-840. PMID 31981860 DOI: 10.1016/j.omtn.2019.09.034 |
0.303 |
|
| 2019 |
Wei M, Liu L, Wang Z. Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 overexpression inhibits the proliferation of cancer cells by reducing RUNX2 expression in triple-negative breast cancer. Oncology Letters. 18: 6775-6780. PMID 31788122 DOI: 10.3892/ol.2019.11001 |
0.317 |
|
| 2019 |
Song Y, Ye M, Zhou J, Wang Z, Zhu X. Targeting E-cadherin expression with small molecules for digestive cancer treatment. American Journal of Translational Research. 11: 3932-3944. PMID 31396310 |
0.371 |
|
| 2019 |
Kuai X, Li L, Chen R, Wang K, Chen M, Cui B, Zhang Y, Li J, Zhu H, Zhou H, Huang J, Qin J, Wang Z, Wei W, Gao D. SCFFBXW7/GSK3β-mediated GFI1 degradation suppresses gastric cancer cell proliferation. Cancer Research. PMID 31289136 DOI: 10.1158/0008-5472.Can-18-4032 |
0.347 |
|
| 2019 |
Song Y, Ye M, Zhou J, Wang ZW, Zhu X. Restoring E-cadherin Expression by Natural Compounds for Anticancer Therapies in Genital and Urinary Cancers. Molecular Therapy Oncolytics. 14: 130-138. PMID 31194121 DOI: 10.1016/j.omto.2019.04.005 |
0.347 |
|
| 2019 |
Song Y, Lin M, Liu Y, Wang ZW, Zhu X. Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers. Stem Cell Research & Therapy. 10: 124. PMID 30999935 DOI: 10.1186/s13287-019-1222-0 |
0.325 |
|
| 2019 |
Kang X, Lin Z, Xu M, Pan J, Wang ZW. Deciphering role of FGFR signalling pathway in pancreatic cancer. Cell Proliferation. e12605. PMID 30945363 DOI: 10.1111/cpr.12605 |
0.401 |
|
| 2019 |
Yang R, Wang Z, Yuan Y, Qian T, Zhou Q. cRGD target liposome delivery system promoted immunogenic cell death through enhanced anticancer potency of a thymidine conjugate under UVA activation as a cancer vaccine. European Journal of Medicinal Chemistry. 167: 499-509. PMID 30784882 DOI: 10.1016/j.ejmech.2019.02.031 |
0.308 |
|
| 2018 |
Hu Z, Zhang M, Wang Z, Song J, Jiang W, Li L, Hu X. An observational study on the clinical features of esophageal cancer followed by multiple primary cancers. Future Oncology (London, England). PMID 30477336 DOI: 10.2217/fon-2018-0621 |
0.327 |
|
| 2018 |
Zheng N, Wang L, Hou Y, Zhou X, He Y, Wang Z. Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer. Cell Cycle (Georgetown, Tex.). PMID 30394832 DOI: 10.1080/15384101.2018.1542897 |
0.528 |
|
| 2018 |
Chen H, Chen W, Zhang X, Hu L, Tang G, Kong J, Wang Z. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer. Oncology Reports. PMID 30365150 DOI: 10.3892/or.2018.6807 |
0.355 |
|
| 2018 |
Xing Z, Sun F, He W, Wang Z, Song X, Zhang F. Erratum: Downregulation of ubiquitin-specific peptidase 39 suppresses the proliferation and induces the apoptosis of human colorectal cancer cells. Oncology Letters. 16: 4790. PMID 30214611 DOI: 10.3892/ol.2018.9234 |
0.374 |
|
| 2018 |
Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH. Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells". Cancer Letters. 423: 153. PMID 29606293 DOI: 10.1016/J.Canlet.2018.03.020 |
0.523 |
|
| 2018 |
Xing Z, Sun F, He W, Wang Z, Song X, Zhang F. Downregulation of ubiquitin-specific peptidase 39 suppresses the proliferation and induces the apoptosis of human colorectal cancer cells. Oncology Letters. 15: 5443-5450. PMID 29556295 DOI: 10.3892/ol.2018.8061 |
0.389 |
|
| 2018 |
Zhou Z, Li Y, Wang X, Hu J, Kuang M, Wang Z, Li S, Xu W, Xiao J. ALCAMstromal cells: role in giant cell tumor of bone progression. Cell Death & Disease. 9: 299. PMID 29463803 DOI: 10.1038/s41419-018-0361-z |
0.322 |
|
| 2017 |
Cheng J, Guo J, Wang Z, North BJ, Tao K, Dai X, Wei W. Functional analysis of Cullin 3 E3 ligases in tumorigenesis. Biochimica Et Biophysica Acta. PMID 29128526 DOI: 10.1016/J.Bbcan.2017.11.001 |
0.421 |
|
| 2017 |
Dai X, Wang Z, Wei W. SPOP-mediated degradation of BRD4 dictates cellular sensitivity to BET inhibitors. Cell Cycle (Georgetown, Tex.). 0. PMID 29108467 DOI: 10.1080/15384101.2017.1388973 |
0.476 |
|
| 2017 |
Wu X, Yan T, Wang Z, Wu X, Cao G, Zhang C. LncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and inhibits apoptosis by regulating miR-27b. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 96: 299-304. PMID 28992472 DOI: 10.1016/j.biopha.2017.08.060 |
0.354 |
|
| 2017 |
Shi Y, Cao T, Huang H, Lian C, Yang Y, Wang Z, Ma J, Xia J. Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells. Cell Cycle (Georgetown, Tex.). 0. PMID 28980872 DOI: 10.1080/15384101.2017.1387699 |
0.51 |
|
| 2017 |
Hou Y, Feng S, Wang L, Zhao Z, Su J, Yin X, Zheng N, Zhou X, Xia J, Wang Z. Inhibition of Notch-1 pathway is involved in rottlerin-induced tumor suppressive function in nasopharyngeal carcinoma cells. Oncotarget. 8: 62120-62130. PMID 28977931 DOI: 10.18632/Oncotarget.19097 |
0.513 |
|
| 2017 |
Wang L, Su J, Zhao Z, Hou Y, Yin X, Zheng N, Zhou X, Yan J, Xia J, Wang Z. MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells. Cell Cycle (Georgetown, Tex.). 1-11. PMID 28898169 DOI: 10.1080/15384101.2017.1367071 |
0.33 |
|
| 2017 |
Lu J, Li X, Wang F, Guo Y, Huang Y, Zhu H, Wang Y, Lu Y, Wang Z. YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a. Experimental Cell Research. PMID 28782557 DOI: 10.1016/j.yexcr.2017.07.039 |
0.362 |
|
| 2017 |
Hou Y, Feng S, Wang L, Zhao Z, Su J, Yin X, Zheng N, Zhou X, Xia J, Wang Z. Inhibition of Notch-1 pathway is involved in rottlerin-induced tumor suppressive function in nasopharyngeal carcinoma cells. Oncotarget. PMID 28723653 DOI: 10.18632/oncotarget.19097 |
0.417 |
|
| 2017 |
Su J, Zhou X, Yin X, Wang L, Zhao Z, Hou Y, Zheng N, Xia J, Wang Z. The effects of Curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer. Biochemical Pharmacology. PMID 28535906 DOI: 10.1016/J.Bcp.2017.05.014 |
0.565 |
|
| 2017 |
Feng S, Wang Y, Zhang R, Yang G, Liang Z, Wang Z, Zhang G. Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells. Oncotargets and Therapy. 10: 2377-2388. PMID 28496336 DOI: 10.2147/OTT.S130055 |
0.318 |
|
| 2017 |
Gao J, Long B, Wang Z. Role of Notch signaling pathway in pancreatic cancer. American Journal of Cancer Research. 7: 173-186. PMID 28337369 |
0.321 |
|
| 2017 |
Zhang Y, Xue YB, Li H, Qiu D, Wang ZW, Tan SS. Inhibition of Cell Survival by Curcumin Is Associated with Downregulation of Cell Division Cycle 20 (Cdc20) in Pancreatic Cancer Cells. Nutrients. 9. PMID 28165402 DOI: 10.3390/nu9020109 |
0.479 |
|
| 2016 |
Zhao Z, Zheng N, Wang L, Hou Y, Zhou X, Wang Z. Rottlerin exhibits antitumor activity via down-regulation of TAZ in non-small cell lung cancer. Oncotarget. PMID 27999199 DOI: 10.18632/Oncotarget.13974 |
0.51 |
|
| 2016 |
Huang J, Mei H, Tang Z, Li J, Zhang X, Lu Y, Huang F, Jin Q, Wang Z. Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27889393 DOI: 10.1016/j.jconrel.2016.11.024 |
0.399 |
|
| 2016 |
Su J, Wang L, Yin X, Zhao Z, Hou Y, Ye X, Zhou X, Wang Z. Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells. American Journal of Cancer Research. 6: 2178-2191. PMID 27822410 |
0.486 |
|
| 2016 |
Zhou X, Su J, Feng S, Wang L, Yin X, Yan J, Wang Z. Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells. Oncotarget. PMID 27738325 DOI: 10.18632/Oncotarget.12596 |
0.576 |
|
| 2016 |
Su J, Zhou X, Wang L, Yin X, Wang Z. Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells. American Journal of Cancer Research. 6: 1949-1962. PMID 27725901 |
0.43 |
|
| 2016 |
Zheng N, Dai X, Wang Z, Wei W. A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle. Cell Cycle (Georgetown, Tex.). 0. PMID 27649746 DOI: 10.1080/15384101.2016.1234552 |
0.305 |
|
| 2016 |
Wang L, Hou Y, Yin X, Su J, Zhao Z, Ye X, Zhou X, Zhou L, Wang Z. Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells. Oncotarget. PMID 27626499 DOI: 10.18632/Oncotarget.11974 |
0.469 |
|
| 2016 |
Yin X, Zhang Y, Su J, Hou Y, Wang L, Ye X, Zhao Z, Zhou X, Li Y, Wang Z. Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells. Oncotarget. PMID 27582552 DOI: 10.18632/Oncotarget.11614 |
0.527 |
|
| 2016 |
Lian S, Zhai X, Wang X, Zhu H, Zhang S, Wang W, Wang Z, Huang J. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer. Medicine. 95: e4328. PMID 27472713 DOI: 10.1097/MD.0000000000004328 |
0.315 |
|
| 2016 |
Chen J, Wang F, Xu J, He Z, Lu Y, Wang Z. The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis. Oncology Reports. PMID 27461225 DOI: 10.3892/or.2016.4951 |
0.332 |
|
| 2016 |
Ma J, Zeng F, Ma C, Pang H, Fang B, Lian C, Yin B, Zhang X, Wang Z, Xia J. Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. American Journal of Cancer Research. 6: 1384-1395. PMID 27429851 |
0.327 |
|
| 2016 |
Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH. Retraction Note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Research and Treatment. PMID 27412558 DOI: 10.1007/s10549-016-3904-y |
0.518 |
|
| 2016 |
Ahmad A, Wang Z, Kong D, Ali R, Ali S, Banerjee S, Sarkar FH. Retraction Note to: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways. Breast Cancer Research and Treatment. PMID 27412557 DOI: 10.1007/S10549-016-3905-X |
0.559 |
|
| 2016 |
Zheng N, Huo Z, Zhang B, Meng M, Cao Z, Wang Z, Zhou Q. Thrombomodulin reduces tumorigenic and metastatic potential of lung cancer cells by up-regulation of E-cadherin and down-regulation of N-cadherin expression. Biochemical and Biophysical Research Communications. PMID 27223053 DOI: 10.1016/J.Bbrc.2016.05.105 |
0.469 |
|
| 2016 |
Wang Z, Wang X, Li J, Yang C, Xing Z, Chen R, Xu F. HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells. Molecular Medicine Reports. PMID 27220399 DOI: 10.3892/mmr.2016.5340 |
0.441 |
|
| 2016 |
Zheng N, Zhou Q, Wang Z, Wei W. Recent advances in SCF ubiquitin ligase complex: Clinical implications. Biochimica Et Biophysica Acta. PMID 27156687 DOI: 10.1016/J.Bbcan.2016.05.001 |
0.317 |
|
| 2016 |
Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J, Wang Z. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/ Akt/mTOR pathway. Oncotarget. PMID 26919096 DOI: 10.18632/Oncotarget.7570 |
0.424 |
|
| 2016 |
Zheng N, Wang Z, Wei W. Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins. The International Journal of Biochemistry & Cell Biology. PMID 26860958 DOI: 10.1016/J.Biocel.2016.02.005 |
0.343 |
|
| 2016 |
Zheng N, Wei W, Wang Z. Emerging roles of FGF signaling in hepatocellular carcinoma Translational Cancer Research. 5: 1-6. DOI: 10.21037/6391 |
0.304 |
|
| 2015 |
Wang Z, Dai X, Zhong J, Inuzuka H, Wan L, Li X, Wang L, Ye X, Sun L, Gao D, Zou L, Wei W. SCF(β-TRCP) promotes cell growth by targeting PR-Set7/Set8 for degradation. Nature Communications. 6: 10185. PMID 26666832 DOI: 10.1038/Ncomms10185 |
0.335 |
|
| 2015 |
Liu Z, Sun Y, Hong H, Zhao S, Zou X, Ma R, Jiang C, Wang Z, Li H, Liu H. 3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells. American Journal of Cancer Research. 5: 2673-2685. PMID 26609475 |
0.411 |
|
| 2015 |
Zhang S, Ma C, Pang H, Zeng F, Cheng L, Fang B, Ma J, Shi Y, Hong H, Chen J, Wang Z, Xia J. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells. Biochemical and Biophysical Research Communications. PMID 26592661 DOI: 10.1016/J.Bbrc.2015.11.071 |
0.47 |
|
| 2015 |
Wang L, Ye X, Cai X, Su J, Ma R, Yin X, Zhou X, Li H, Wang Z. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells. Oncotarget. PMID 26046466 DOI: 10.18632/Oncotarget.4090 |
0.495 |
|
| 2015 |
Gao JK, Wang LX, Long B, Ye XT, Su JN, Yin XY, Zhou XX, Wang ZW. Arsenic Trioxide Inhibits Cell Growth and Invasion via Down- Regulation of Skp2 in Pancreatic Cancer Cells. Asian Pacific Journal of Cancer Prevention : Apjcp. 16: 3805-10. PMID 25987041 DOI: 10.7314/Apjcp.2015.16.9.3805 |
0.56 |
|
| 2015 |
Wang L, Zhang J, Wan L, Zhou X, Wang Z, Wei W. Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacology & Therapeutics. 151: 141-151. PMID 25850036 DOI: 10.1016/J.Pharmthera.2015.04.002 |
0.479 |
|
| 2015 |
Li B, Wang Z, Zhong Y, Lan J, Li X, Lin H. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway. Medical Oncology (Northwood, London, England). 32: 66. PMID 25691296 DOI: 10.1007/s12032-015-0531-0 |
0.336 |
|
| 2015 |
Ma J, Fang B, Zeng F, Ma C, Pang H, Cheng L, Shi Y, Wang H, Yin B, Xia J, Wang Z. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Oncotarget. 6: 1740-9. PMID 25638153 DOI: 10.18632/ONCOTARGET.2714 |
0.334 |
|
| 2015 |
Su J, Yin X, Zhou X, Wei W, Wang Z. The functions of F-box proteins in regulating the epithelial to mesenchymal transition. Current Pharmaceutical Design. 21: 1311-7. PMID 25506894 DOI: 10.2174/1381612821666141211144203 |
0.371 |
|
| 2015 |
Liu J, Shaik S, Dai X, Wu Q, Zhou X, Wang Z, Wei W. Targeting the ubiquitin pathway for cancer treatment. Biochimica Et Biophysica Acta. 1855: 50-60. PMID 25481052 DOI: 10.1016/J.Bbcan.2014.11.005 |
0.444 |
|
| 2015 |
Zhang Y, Sun M, Shi W, Yang Q, Chen C, Wang Z, Zhou X. Arsenic trioxide suppresses transcription of hTERT through down-regulation of multiple transcription factors in HL-60 leukemia cells. Toxicology Letters. 232: 481-9. PMID 25436934 DOI: 10.1016/j.toxlet.2014.11.028 |
0.339 |
|
| 2014 |
Qi H, Zuo DY, Bai ZS, Xu JW, Li ZQ, Shen QR, Wang ZW, Zhang WG, Wu YL. COH-203, a novel microtubule inhibitor, exhibits potent anti-tumor activity via p53-dependent senescence in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 455: 262-8. PMID 25449279 DOI: 10.1016/j.bbrc.2014.11.001 |
0.302 |
|
| 2014 |
Ma J, Fang B, Zeng F, Pang H, Zhang J, Shi Y, Wu X, Cheng L, Ma C, Xia J, Wang Z. Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells. Toxicology Letters. 231: 82-91. PMID 25256401 DOI: 10.1016/j.toxlet.2014.09.014 |
0.385 |
|
| 2014 |
Ye X, Wang L, Shang B, Wang Z, Wei W. NEDD4: a promising target for cancer therapy. Current Cancer Drug Targets. 14: 549-56. PMID 25088038 DOI: 10.2174/1568009614666140725092430 |
0.469 |
|
| 2014 |
Liu P, Wang Z, Wei W. Phosphorylation of Akt at the C-terminal tail triggers Akt activation. Cell Cycle (Georgetown, Tex.). 13: 2162-4. PMID 24933731 DOI: 10.4161/Cc.29584 |
0.324 |
|
| 2014 |
Wang L, Ye X, Liu Y, Wei W, Wang Z. Aberrant regulation of FBW7 in cancer. Oncotarget. 5: 2000-15. PMID 24899581 DOI: 10.18632/Oncotarget.1859 |
0.392 |
|
| 2014 |
Liu P, Begley M, Michowski W, Inuzuka H, Ginzberg M, Gao D, Tsou P, Gan W, Papa A, Kim BM, Wan L, Singh A, Zhai B, Yuan M, Wang Z, et al. Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature. 508: 541-5. PMID 24670654 DOI: 10.1038/Nature13079 |
0.401 |
|
| 2014 |
Liu J, Wan L, Liu P, Inuzuka H, Liu J, Wang Z, Wei W. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway. Oncotarget. 5: 1026-37. PMID 24657926 DOI: 10.18632/Oncotarget.1675 |
0.443 |
|
| 2014 |
Yang Q, Huang J, Wu Q, Cai Y, Zhu L, Lu X, Chen S, Chen C, Wang Z. Acquisition of epithelial-mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells. British Journal of Cancer. 110: 1958-67. PMID 24642627 DOI: 10.1038/Bjc.2014.136 |
0.418 |
|
| 2014 |
Wang R, Cheng L, Xia J, Wang Z, Wu Q, Wang Z. Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cancer cells. Current Cancer Drug Targets. 14: 407-17. PMID 24575976 DOI: 10.2174/1568009614666140226114015 |
0.356 |
|
| 2014 |
Lu Y, Lu J, Li X, Zhu H, Fan X, Zhu S, Wang Y, Guo Q, Wang L, Huang Y, Zhu M, Wang Z. MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. Bmc Cancer. 14: 85. PMID 24521357 DOI: 10.1186/1471-2407-14-85 |
0.342 |
|
| 2014 |
Xia J, Cheng L, Mei C, Ma J, Shi Y, Zeng F, Wang Z, Wang Z. Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells. Current Pharmaceutical Design. 20: 5348-53. PMID 24479798 DOI: 10.2174/1381612820666140128215756 |
0.354 |
|
| 2014 |
Wang Z. Advances with microRNAs in tumorigenesis and cancer therapy. Current Pharmaceutical Design. 20: 5245-5245. PMID 24479796 DOI: 10.2174/1381612820666140128223856 |
0.403 |
|
| 2014 |
Wei M, He Q, Yang Z, Wang Z, Zhang Q, Liu B, Gu Q, Su L, Yu Y, Zhu Z, Zhang G. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone. Bmc Cancer. 14: 10. PMID 24401087 DOI: 10.1186/1471-2407-14-10 |
0.369 |
|
| 2014 |
Liu F, Gong J, Huang W, Wang Z, Wang M, Yang J, Wu C, Wu Z, Han B. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes. Oncogene. 33: 4813-22. PMID 24166509 DOI: 10.1038/Onc.2013.428 |
0.416 |
|
| 2014 |
Xia J, Li Y, Yang Q, Mei C, Chen Z, Bao B, Ahmad A, Miele L, Sarkar F, Wang Z. Xia, J.; et al., Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer. Int. J. Mol. Sci. 2012, 13, 9627–9641 International Journal of Molecular Sciences. 15: 14907-14908. DOI: 10.3390/Ijms150814907 |
0.517 |
|
| 2014 |
Wang Z, Banerjee S, Ahmad A, Li Y, Azmi AS. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of notch and NF-κB signaling pathways (PLoS ONE (2011) 6, 6, (e20537) DOI: 10.1371/journal.pone.0020537) Plos One. 9. DOI: 10.1371/Journal.Pone.0101032 |
0.378 |
|
| 2014 |
Ahmad A, Ali S, Wang Z, Ali AS, Sethi S, Sakr WA, Raz A, Rahman KM. Erratum: 3,3′-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1 (International Journal of Cancer (2011) 129:7 (1781-1791)) International Journal of Cancer. 135. DOI: 10.1002/Ijc.28918 |
0.484 |
|
| 2013 |
Zhong J, Shaik S, Wan L, Tron AE, Wang Z, Sun L, Inuzuka H, Wei W. SCF β-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration. Oncotarget. 4: 2339-53. PMID 24318128 DOI: 10.18632/Oncotarget.1446 |
0.537 |
|
| 2013 |
Li Y, Ma J, Qian X, Wu Q, Xia J, Miele L, Sarkar FH, Wang Z. Regulation of EMT by Notch signaling pathway in tumor progression. Current Cancer Drug Targets. 13: 957-62. PMID 24168187 DOI: 10.2174/15680096113136660101 |
0.518 |
|
| 2013 |
Wu Q, Wang R, Yang Q, Hou X, Chen S, Hou Y, Chen C, Yang Y, Miele L, Sarkar FH, Chen Y, Wang Z. Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway. Oncotarget. 4: 1999-2009. PMID 24158561 DOI: 10.18632/Oncotarget.1471 |
0.48 |
|
| 2013 |
Ma J, Xia J, Miele L, Sarkar FH, Wang Z. Notch Signaling Pathway in Pancreatic Cancer Progression. Pancreatic Disorders & Therapy. 3. PMID 24027656 DOI: 10.4172/2165-7092.1000114 |
0.584 |
|
| 2013 |
Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q. Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. European Journal of Cancer (Oxford, England : 1990). 49: 3914-23. PMID 23992642 DOI: 10.1016/J.Ejca.2013.07.148 |
0.552 |
|
| 2013 |
Cao Z, Shang B, Zhang G, Miele L, Sarkar FH, Wang Z, Zhou Q. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis. Biochimica Et Biophysica Acta. 1836: 273-86. PMID 23933263 DOI: 10.1016/J.Bbcan.2013.08.001 |
0.559 |
|
| 2013 |
Ma J, Zhang Q, Chen S, Fang B, Yang Q, Chen C, Miele L, Sarkar FH, Xia J, Wang Z. Mitochondrial dysfunction promotes breast cancer cell migration and invasion through HIF1α accumulation via increased production of reactive oxygen species. Plos One. 8: e69485. PMID 23922721 DOI: 10.1371/Journal.Pone.0069485 |
0.545 |
|
| 2013 |
Lu Y, Zhu H, Shan H, Lu J, Chang X, Li X, Lu J, Fan X, Zhu S, Wang Y, Guo Q, Wang L, Huang Y, Zhu M, Wang Z. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Letters. 340: 113-23. PMID 23872274 DOI: 10.1016/j.canlet.2013.07.009 |
0.377 |
|
| 2013 |
Ma J, Cheng L, Liu H, Zhang J, Shi Y, Zeng F, Miele L, Sarkar FH, Xia J, Wang Z. Genistein down-regulates miR-223 expression in pancreatic cancer cells Current Drug Targets. 14: 1150-1156. PMID 23834147 DOI: 10.2174/13894501113149990187 |
0.537 |
|
| 2013 |
Wang R, Ma J, Wu Q, Xia J, Miele L, Sarkar FH, Wang Z. Functional role of miR-34 family in human cancer Current Drug Targets. 14: 1185-1191. PMID 23834144 DOI: 10.2174/13894501113149990191 |
0.458 |
|
| 2013 |
Zhang G, Yang P, Guo P, Miele L, Sarkar FH, Wang Z, Zhou Q. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer. Biochimica Et Biophysica Acta. 1836: 49-59. PMID 23523716 DOI: 10.1016/J.Bbcan.2013.03.001 |
0.519 |
|
| 2013 |
Wu Q, Hou X, Xia J, Qian X, Miele L, Sarkar FH, Wang Z. Emerging roles of PDGF-D in EMT progression during tumorigenesis Cancer Treatment Reviews. 39: 640-646. PMID 23261166 DOI: 10.1016/J.Ctrv.2012.11.006 |
0.529 |
|
| 2013 |
Tan Y, Wu Q, Xia J, Miele L, Sarkar FH, Wang Z. Systems biology approaches in identifying the targets of natural compounds for cancer therapy Current Drug Discovery Technologies. 10: 139-146. PMID 23237676 DOI: 10.2174/1570163811310020006 |
0.531 |
|
| 2013 |
Wang Z, Wan L, Zhong J, Inuzuka H, Liu P, Sarkar FH, Wei W. Cdc20: a potential novel therapeutic target for cancer treatment. Current Pharmaceutical Design. 19: 3210-4. PMID 23151139 DOI: 10.2174/1381612811319180005 |
0.604 |
|
| 2013 |
Wang Z, Ali S, Banerjee S, Bao B, Li Y, Azmi AS, Korc M, Sarkar FH. Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype. Journal of Cellular Physiology. 228: 556-62. PMID 22806240 DOI: 10.1002/Jcp.24162 |
0.593 |
|
| 2013 |
Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GPV, Sarkar FH. Regulation of FOXO3a/β-catenin/GSK-3β signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. Journal of Biological Chemistry. 288: 34755-34755. DOI: 10.1074/Jbc.A113.701978 |
0.561 |
|
| 2012 |
Xia J, Sarkar FH, Wang Z. Emerging Role of MicroRNA in Pancreatic Cancer. Pancreatic Disorders & Therapy. 2: e114. PMID 24851195 DOI: 10.4172/2165-7092.1000E114 |
0.537 |
|
| 2012 |
Tan Y, Miele L, Sarkar FH, Wang Z. Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer. Pancreatic Disorders & Therapy. 2: 1000e128. PMID 23378937 DOI: 10.4172/2165-7092.1000E128 |
0.48 |
|
| 2012 |
Wang Z, Inuzuka H, Zhong J, Liu P, Sarkar FH, Sun Y, Wei W. Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2. Oncotarget. 3: 1294-300. PMID 23230084 DOI: 10.18632/Oncotarget.740 |
0.532 |
|
| 2012 |
Wu Q, Miele L, Sarkar FH, Wang Z. The Role of EMT in Pancreatic Cancer Progression. Pancreatic Disorders & Therapy. 2. PMID 23145368 DOI: 10.4172/2165-7092.1000E121 |
0.619 |
|
| 2012 |
Xia J, Duan Q, Ahmad A, Bao B, Banerjee S, Shi Y, Ma J, Geng J, Chen Z, Rahman KM, Miele L, Sarkar FH, Wang Z. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Current Drug Targets. 13: 1750-6. PMID 23140286 DOI: 10.2174/138945012804545597 |
0.581 |
|
| 2012 |
Wang Z, Inuzuka H, Zhong J, Fukushima H, Wan L, Liu P, Wei W. DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction. Oncotarget. 3: 1026-35. PMID 22976441 DOI: 10.18632/Oncotarget.640 |
0.312 |
|
| 2012 |
Xia J, Li Y, Yang Q, Mei C, Chen Z, Bao B, Ahmad A, Miele L, Sarkar FH, Wang Z. Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer. International Journal of Molecular Sciences. 13: 9627-41. PMID 22949821 DOI: 10.3390/Ijms13089627 |
0.648 |
|
| 2012 |
Inuzuka H, Gao D, Finley LW, Yang W, Wan L, Fukushima H, Chin YR, Zhai B, Shaik S, Lau AW, Wang Z, Gygi SP, Nakayama K, Teruya-Feldstein J, Toker A, et al. Acetylation-dependent regulation of Skp2 function. Cell. 150: 179-93. PMID 22770219 DOI: 10.1016/J.Cell.2012.05.038 |
0.433 |
|
| 2012 |
Ji X, Wang Z, Sarkar FH, Gupta SV. Delta-tocotrienol augments cisplatin-induced suppression of non-small cell lung cancer cells via inhibition of the Notch-1 pathway. Anticancer Research. 32: 2647-55. PMID 22753722 |
0.565 |
|
| 2012 |
Wang Z, Zhong J, Inuzuka H, Gao D, Shaik S, Sarkar FH, Wei W. An evolving role for DEPTOR in tumor development and progression. Neoplasia (New York, N.Y.). 14: 368-75. PMID 22745583 DOI: 10.1593/Neo.12542 |
0.617 |
|
| 2012 |
Xia J, Chen C, Chen Z, Miele L, Sarkar FH, Wang Z. Targeting pancreatic cancer stem cells for cancer therapy. Biochimica Et Biophysica Acta. 1826: 385-99. PMID 22728049 DOI: 10.1016/J.Bbcan.2012.06.002 |
0.626 |
|
| 2012 |
Wang Z, Wei W, Sarkar FH. miR-23a, a critical regulator of "migR"ation and metastasis in colorectal cancer. Cancer Discovery. 2: 489-91. PMID 22684455 DOI: 10.1158/2159-8290.Cd-12-0177 |
0.533 |
|
| 2012 |
Wang Z, Inuzuka H, Zhong J, Wan L, Fukushima H, Sarkar FH, Wei W. Tumor suppressor functions of FBW7 in cancer development and progression. Febs Letters. 586: 1409-18. PMID 22673505 DOI: 10.1016/J.Febslet.2012.03.017 |
0.565 |
|
| 2012 |
Ma YC, Shi C, Zhang YN, Wang LG, Liu H, Jia HT, Zhang YX, Sarkar FH, Wang ZS. The tyrosine kinase c-Src directly mediates growth factor-induced Notch-1 and Furin interaction and Notch-1 activation in pancreatic cancer cells. Plos One. 7: e33414. PMID 22479394 DOI: 10.1371/Journal.Pone.0033414 |
0.472 |
|
| 2012 |
Ji X, Wang Z, Geamanu A, Goja A, Sarkar FH, Gupta SV. Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells. International Journal of Cancer. 131: 2668-77. PMID 22438124 DOI: 10.1002/Ijc.27549 |
0.559 |
|
| 2012 |
Wang G, Wang Z, Sarkar FH, Wei W. Targeting prostate cancer stem cells for cancer therapy. Discovery Medicine. 13: 135-42. PMID 22369972 |
0.484 |
|
| 2012 |
Wang Z, Fukushima H, Inuzuka H, Wan L, Liu P, Gao D, Sarkar FH, Wei W. Skp2 is a promising therapeutic target in breast cancer. Frontiers in Oncology. 1. PMID 22279619 DOI: 10.3389/Fonc.2011.00057 |
0.572 |
|
| 2012 |
Wang Z, Inuzuka H, Fukushima H, Wan L, Gao D, Shaik S, Sarkar FH, Wei W. Emerging roles of the FBW7 tumour suppressor in stem cell differentiation. Embo Reports. 13: 36-43. PMID 22157894 DOI: 10.1038/Embor.2011.231 |
0.524 |
|
| 2012 |
Bao B, Ali S, Banerjee S, Wang Z, Logna F, Azmi AS, Kong D, Ahmad A, Li Y, Padhye S, Sarkar FH. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Research. 72: 335-45. PMID 22108826 DOI: 10.1158/0008-5472.Can-11-2182 |
0.607 |
|
| 2012 |
Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 5: 355-64. PMID 22086681 DOI: 10.1158/1940-6207.Capr-11-0299 |
0.61 |
|
| 2012 |
Wang Z, Gao D, Fukushima H, Inuzuka H, Liu P, Wan L, Sarkar FH, Wei W. Skp2: a novel potential therapeutic target for prostate cancer. Biochimica Et Biophysica Acta. 1825: 11-7. PMID 21963805 DOI: 10.1016/J.Bbcan.2011.09.002 |
0.568 |
|
| 2012 |
Shamim U, Hanif S, Albanyan A, Beck FW, Bao B, Wang Z, Banerjee S, Sarkar FH, Mohammad RM, Hadi SM, Azmi AS. Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer. Journal of Cellular Physiology. 227: 1493-500. PMID 21678400 DOI: 10.1002/Jcp.22865 |
0.545 |
|
| 2011 |
Wang Z, Fukushima H, Gao D, Inuzuka H, Wan L, Lau AW, Liu P, Wei W. The two faces of FBW7 in cancer drug resistance. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 33: 851-9. PMID 22006825 DOI: 10.1002/Bies.201100101 |
0.409 |
|
| 2011 |
Banerjee S, Kong D, Wang Z, Bao B, Hillman GG, Sarkar FH. Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic. Mutation Research. 728: 47-66. PMID 21703360 DOI: 10.1016/J.Mrrev.2011.06.001 |
0.614 |
|
| 2011 |
Li Y, Kong D, Wang Z, Ahmad A, Bao B, Padhye S, Sarkar FH. Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 4: 1495-506. PMID 21680704 DOI: 10.1158/1940-6207.Capr-11-0077 |
0.586 |
|
| 2011 |
Wang Z, Banerjee S, Ahmad A, Li Y, Azmi AS, Gunn JR, Kong D, Bao B, Ali S, Gao J, Mohammad RM, Miele L, Korc M, Sarkar FH. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. Plos One. 6: e20537. PMID 21673986 DOI: 10.1371/Journal.Pone.0020537 |
0.495 |
|
| 2011 |
Kong D, Li Y, Wang Z, Sarkar FH. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? Cancers. 3: 716-29. PMID 21643534 DOI: 10.3390/Cancers30100716 |
0.588 |
|
| 2011 |
Azmi AS, Banerjee S, Ali S, Wang Z, Bao B, Beck FW, Maitah M, Choi M, Shields TF, Philip PA, Sarkar FH, Mohammad RM. Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors. Oncotarget. 2: 378-92. PMID 21623005 DOI: 10.18632/Oncotarget.269 |
0.776 |
|
| 2011 |
Ahmad A, Wang Z, Wojewoda C, Ali R, Kong D, Maitah MY, Banerjee S, Bao B, Padhye S, Sarkar FH. Garcinol-induced apoptosis in prostate and pancreatic cancer cells is mediated by NF- kappaB signaling. Frontiers in Bioscience (Elite Edition). 3: 1483-92. PMID 21622152 DOI: 10.2741/E349 |
0.817 |
|
| 2011 |
Ji X, Wang Z, Geamanu A, Sarkar FH, Gupta SV. Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation. Journal of Cellular Biochemistry. 112: 2773-83. PMID 21598300 DOI: 10.1002/Jcb.23184 |
0.633 |
|
| 2011 |
Wei M, Zhu L, Li Y, Chen W, Han B, Wang Z, He J, Yao H, Yang Z, Zhang Q, Liu B, Gu Q, Zhu Z, Shen K. Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model. Cancer Science. 102: 1537-44. PMID 21521417 DOI: 10.1111/j.1349-7006.2011.01969.x |
0.353 |
|
| 2011 |
Wang Z, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Anticancer Research. 31: 1105-13. PMID 21508353 |
0.573 |
|
| 2011 |
Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. Journal of Cellular Biochemistry. 112: 2296-306. PMID 21503965 DOI: 10.1002/Jcb.23150 |
0.602 |
|
| 2011 |
Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Letters. 307: 26-36. PMID 21463919 DOI: 10.1016/J.Canlet.2011.03.012 |
0.592 |
|
| 2011 |
Wei M, Wang Z, Yao H, Yang Z, Zhang Q, Liu B, Yu Y, Su L, Zhu Z, Gu Q. P27(Kip1), regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells. Bmc Cancer. 11: 109. PMID 21439087 DOI: 10.1186/1471-2407-11-109 |
0.305 |
|
| 2011 |
Bao B, Ali S, Kong D, Sarkar SH, Wang Z, Banerjee S, Aboukameel A, Padhye S, Philip PA, Sarkar FH. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. Plos One. 6: e17850. PMID 21408027 DOI: 10.1371/Journal.Pone.0017850 |
0.633 |
|
| 2011 |
Ahmad A, Aboukameel A, Kong D, Wang Z, Sethi S, Chen W, Sarkar FH, Raz A. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells Cancer Research. 71: 3400-3409. PMID 21389093 DOI: 10.1158/0008-5472.Can-10-0965 |
0.535 |
|
| 2011 |
Liao S, Xia J, Chen Z, Zhang S, Ahmad A, Miele L, Sarkar FH, Wang Z. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways. Journal of Cellular Biochemistry. 112: 1055-65. PMID 21308734 DOI: 10.1002/Jcb.23019 |
0.616 |
|
| 2011 |
Ahmad A, Ali S, Wang Z, Ali AS, Sethi S, Sakr WA, Raz A, Rahman KMW. 3,3′-diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1 International Journal of Cancer. 129: 1781-1791. PMID 21154750 DOI: 10.1002/Ijc.25839 |
0.485 |
|
| 2011 |
Bao B, Wang Z, Li Y, Kong D, Ali S, Banerjee S, Ahmad A, Sarkar FH. The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochimica Et Biophysica Acta. 1815: 135-46. PMID 21129444 DOI: 10.1016/J.Bbcan.2010.11.003 |
0.495 |
|
| 2011 |
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Sarkar FH. Pancreatic cancer: understanding and overcoming chemoresistance. Nature Reviews. Gastroenterology & Hepatology. 8: 27-33. PMID 21102532 DOI: 10.1038/Nrgastro.2010.188 |
0.605 |
|
| 2011 |
Azmi AS, Philip PA, Beck FWJ, Wang Z, Banerjee S, Wang S, Yang D, Sarkar FH, Mohammad RM. MI-219-zinc combination: A new paradigm in MDM2 inhibitor-based therapy Oncogene. 30: 117-126. PMID 20818437 DOI: 10.1038/Onc.2010.403 |
0.5 |
|
| 2011 |
Azmi AS, Wang Z, Philip PA, Mohammad RM, Sarkar FH. Emerging Bcl-2 inhibitors for the treatment of cancer. Expert Opinion On Emerging Drugs. 16: 59-70. PMID 20812891 DOI: 10.1517/14728214.2010.515210 |
0.57 |
|
| 2011 |
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Wojewoda C, Miele L, Sarkar FH. Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells. Journal of Cellular Biochemistry. 112: 78-88. PMID 20658545 DOI: 10.1002/Jcb.22770 |
0.648 |
|
| 2011 |
Ahmad A, Wang Z, Kong D, Ali R, Ali S, Banerjee S, Sarkar FH. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways. Breast Cancer Research and Treatment. 126: 15-25. PMID 20379844 DOI: 10.1007/S10549-010-0883-2 |
0.565 |
|
| 2011 |
Wang Z, Banerjee S, Ahmad A, Azmi AS, Bao B, Ali S, Mohammad RM, Miele L, Korc M, Sarkar FH. Abstract 2385: Activated Kras and INK4a/Arf deficiency cooperate to produce pancreatic cancer involved with Notch and NF-κB pathways Cancer Research. 71: 2385-2385. DOI: 10.1158/1538-7445.Am2011-2385 |
0.585 |
|
| 2011 |
Bao B, Ali S, Kong D, Sarkar SH, Wang Z, Banerjee S, Aboukameel A, Padhye S, Philp PA, Sarkar FH. Abstract 173: Targeted killing of cancer stem-like cells by a novel analogue of curcumin Cancer Research. 71: 173-173. DOI: 10.1158/1538-7445.Am2011-173 |
0.628 |
|
| 2010 |
Li Y, VandenBoom TG, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH. Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells. Cancer Research. 70: 5703. PMID 25242818 DOI: 10.1158/1538-7445.Am10-5703 |
0.566 |
|
| 2010 |
Ullah MF, Ahmad A, Zubair H, Khan HY, Wang Z, Sarkar FH, Hadi SM. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Molecular Nutrition & Food Research. 55: 553-9. PMID 21462322 DOI: 10.1002/Mnfr.201000329 |
0.587 |
|
| 2010 |
Azmi AS, Wang Z, Philip PA, Mohammad RM, Sarkar FH. Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations. Molecular Cancer Therapeutics. 9: 3137-44. PMID 21041384 DOI: 10.1158/1535-7163.Mct-10-0642 |
0.53 |
|
| 2010 |
Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, Sarkar FH, Mohammad RM. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutrition and Cancer. 62: 938-46. PMID 20924969 DOI: 10.1080/01635581.2010.509832 |
0.641 |
|
| 2010 |
Banerjee S, Kong D, Azmi AS, Wang Z, Ahmad A, Sethi S, Sarkar FH. Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo. International Journal of Cancer. 128: 1240-50. PMID 20824697 DOI: 10.1002/Ijc.25658 |
0.588 |
|
| 2010 |
Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. Plos One. 5: e12445. PMID 20805998 DOI: 10.1371/Journal.Pone.0012445 |
0.6 |
|
| 2010 |
Sarkar FH, Li Y, Wang Z, Kong D. The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Reviews. 29: 383-94. PMID 20711635 DOI: 10.1007/S10555-010-9233-4 |
0.607 |
|
| 2010 |
Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, Sarkar FH. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 13: 109-18. PMID 20692200 DOI: 10.1016/J.Drup.2010.07.001 |
0.549 |
|
| 2010 |
Wang Z, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D, Sarkar FH. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochimica Et Biophysica Acta. 1806: 258-67. PMID 20600632 DOI: 10.1016/J.Bbcan.2010.06.001 |
0.576 |
|
| 2010 |
Sarkar FH, Li Y, Wang Z, Kong D. Novel targets for prostate cancer chemoprevention. Endocrine-Related Cancer. 17: R195-212. PMID 20576802 DOI: 10.1677/Erc-10-0074 |
0.602 |
|
| 2010 |
Wang Z, Li Y, Sarkar FH. Notch signaling proteins: legitimate targets for cancer therapy. Current Protein & Peptide Science. 11: 398-408. PMID 20491628 DOI: 10.2174/138920310791824039 |
0.607 |
|
| 2010 |
Wang Z, Ahmad A, Li Y, Kong D, Azmi AS, Banerjee S, Sarkar FH. Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochimica Et Biophysica Acta. 1806: 122-30. PMID 20434526 DOI: 10.1016/J.Bbcan.2010.04.003 |
0.527 |
|
| 2010 |
Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, Wang Z, Philip PA, Sarkar FH. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Research. 70: 3606-17. PMID 20388782 DOI: 10.1158/0008-5472.Can-09-4598 |
0.572 |
|
| 2010 |
Azmi AS, Philip PA, Aboukameel A, Wang Z, Banerjee S, Zafar SF, Goustin AS, Almhanna K, Yang D, Sarkar FH, Mohammad RM. Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy. Current Cancer Drug Targets. 10: 319-31. PMID 20370686 DOI: 10.2174/156800910791190229 |
0.58 |
|
| 2010 |
Wang Z, Ahmad A, Banerjee S, Azmi A, Kong D, Li Y, Sarkar FH. FoxM1 is a novel target of a natural agent in pancreatic cancer. Pharmaceutical Research. 27: 1159-68. PMID 20354770 DOI: 10.1007/S11095-010-0106-X |
0.609 |
|
| 2010 |
Sarkar FH, Li Y, Wang Z, Padhye S. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Current Pharmaceutical Design. 16: 1801-12. PMID 20345353 DOI: 10.2174/138161210791208956 |
0.587 |
|
| 2010 |
Li Y, Kong D, Wang Z, Sarkar FH. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharmaceutical Research. 27: 1027-41. PMID 20306121 DOI: 10.1007/S11095-010-0105-Y |
0.554 |
|
| 2010 |
Sarkar FH, Li Y, Wang Z, Kong D, Ali S. Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 13: 57-66. PMID 20236855 DOI: 10.1016/J.Drup.2010.02.001 |
0.539 |
|
| 2010 |
Azmi AS, Aboukameel A, Banerjee S, Wang Z, Mohammad M, Wu J, Wang S, Yang D, Philip PA, Sarkar FH, Mohammad RM. MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function. European Journal of Cancer (Oxford, England : 1990). 46: 1122-31. PMID 20156675 DOI: 10.1016/J.Ejca.2010.01.015 |
0.539 |
|
| 2010 |
Li Y, Vandenboom TG, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Research. 70: 1486-95. PMID 20124483 DOI: 10.1158/0008-5472.Can-09-2792 |
0.618 |
|
| 2010 |
Ahmad A, Wang Z, Ali R, Maitah MY, Kong D, Banerjee S, Padhye S, Sarkar FH. Apoptosis-inducing effect of garcinol is mediated by NF-kappaB signaling in breast cancer cells. Journal of Cellular Biochemistry. 109: 1134-41. PMID 20108249 DOI: 10.1002/Jcb.22492 |
0.809 |
|
| 2010 |
Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. Journal of Cellular Biochemistry. 109: 726-36. PMID 20052673 DOI: 10.1002/Jcb.22451 |
0.625 |
|
| 2010 |
Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Current Drug Targets. 11: 745-51. PMID 20041844 DOI: 10.2174/138945010791170860 |
0.56 |
|
| 2010 |
Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treatment Reviews. 36: 151-6. PMID 20022709 DOI: 10.1016/J.Ctrv.2009.11.006 |
0.576 |
|
| 2010 |
Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Letters. 292: 141-8. PMID 20022691 DOI: 10.1016/J.Canlet.2009.11.012 |
0.506 |
|
| 2010 |
Wang Z, Li Y, Sarkar FH. Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression. Current Stem Cell Research & Therapy. 5: 74-80. PMID 19951255 DOI: 10.2174/157488810790442813 |
0.613 |
|
| 2010 |
Wang ZW, Guo CC, Xie WZ, Liu CZ, Xiao CG, Tan Z. Novel phosphoramidates with porphine and nitrogenous drug: one-pot synthesis and orientation to cancer cells. European Journal of Medicinal Chemistry. 45: 890-5. PMID 19942325 DOI: 10.1016/J.Ejmech.2009.11.027 |
0.364 |
|
| 2010 |
Banerjee S, Choi M, Aboukameel A, Wang Z, Mohammad M, Chen J, Yang D, Sarkar FH, Mohammad RM. Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells. Pancreas. 39: 323-31. PMID 19823097 DOI: 10.1097/Mpa.0B013E3181Bb95E7 |
0.582 |
|
| 2010 |
Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Research and Treatment. 122: 337-46. PMID 19813088 DOI: 10.1007/S10549-009-0572-1 |
0.621 |
|
| 2010 |
Ahmad A, Kong D, Wang Z, Sarkar SH, Banerjee S, Sarkar FH. Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells. Journal of Cellular Biochemistry. 108: 916-25. PMID 19693769 DOI: 10.1002/Jcb.22323 |
0.601 |
|
| 2010 |
Azmi AS, Philip PA, Aboukameel A, Banerjee S, Wang Z, Wang S, Yang D, Sarkar FH, Mohammad RM. Abstract 4535: MDM2 inhibitor MI-319 in combination with cisplatin/oxaliplatin is an effective treatment for pancreatic cancer independent of p53 function Cancer Research. 70: 4535-4535. DOI: 10.1158/1538-7445.Am10-4535 |
0.567 |
|
| 2010 |
Rahman K, Ahmad A, Ali S, Wang Z, Sethi S, Sakr W. Abstract 3803: 3,3-Diindolylmethane enhances Taxotere-induced apoptosis in breast cancer cells through FoXM1 downregulation Cancer Research. 70: 3803-3803. DOI: 10.1158/1538-7445.Am10-3803 |
0.51 |
|
| 2010 |
Ahmad A, Kong D, Wang Z, Ali R, Banerjee S, Sarkar FH. Abstract 3118: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulation of Notch and NF-κB signaling pathways Cancer Research. 70: 3118-3118. DOI: 10.1158/1538-7445.Am10-3118 |
0.573 |
|
| 2010 |
Banerjee S, Wang Z, Azmi A, Kong D, Ahmad A, Sarkar FH. Abstract 2561: Genistein restored chemosensitivity to oxaliplatin in gemcitabine resistant pancreatic cancer cells in vitro and in orthotopic xenograft mouse model Cancer Research. 70: 2561-2561. DOI: 10.1158/1538-7445.Am10-2561 |
0.63 |
|
| 2009 |
Ahmad A, Banerjee S, Wang Z, Kong D, Majumdar AP, Sarkar FH. Aging and inflammation: etiological culprits of cancer. Current Aging Science. 2: 174-86. PMID 19997527 DOI: 10.2174/1874609810902030174 |
0.516 |
|
| 2009 |
Li Y, VandenBoom TG, Kong D, Wang Z, Ali S, Philip PA, Sarkar FH. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Research. 69: 6704-12. PMID 19654291 DOI: 10.1158/0008-5472.Can-09-1298 |
0.585 |
|
| 2009 |
Banerjee S, Kaseb AO, Wang Z, Kong D, Mohammad M, Padhye S, Sarkar FH, Mohammad RM. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Research. 69: 5575-83. PMID 19549912 DOI: 10.1158/0008-5472.Can-08-4235 |
0.626 |
|
| 2009 |
Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR, Sarkar FH. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells (Dayton, Ohio). 27: 1712-21. PMID 19544444 DOI: 10.1002/Stem.101 |
0.561 |
|
| 2009 |
Banerjee S, Wang Z, Kong D, Sarkar FH. 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer. Cancer Research. 69: 5592-600. PMID 19531648 DOI: 10.1158/0008-5472.Can-09-0838 |
0.639 |
|
| 2009 |
Rahman KW, Banerjee S, Ali S, Ahmad A, Wang Z, Kong D, Sakr WA. 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Cancer Research. 69: 4468-4475. PMID 19435906 DOI: 10.1158/0008-5472.Can-08-4423 |
0.511 |
|
| 2009 |
Ahmad A, Kong D, Sarkar SH, Wang Z, Banerjee S, Sarkar FH. Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration. Journal of Cellular Biochemistry. 107: 516-27. PMID 19330806 DOI: 10.1002/Jcb.22152 |
0.611 |
|
| 2009 |
Wang Z, Azmi AS, Ahmad A, Banerjee S, Wang S, Sarkar FH, Mohammad RM. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway. Cancer Research. 69: 2757-65. PMID 19318573 DOI: 10.1158/0008-5472.Can-08-3060 |
0.639 |
|
| 2009 |
Sarkar FH, Li Y, Wang Z, Kong D. Cellular signaling perturbation by natural products. Cellular Signalling. 21: 1541-7. PMID 19298854 DOI: 10.1016/J.Cellsig.2009.03.009 |
0.63 |
|
| 2009 |
Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, Azmi AS, Ali S, Abbruzzese JL, Gallick GE, Sarkar FH. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Research. 69: 2400-7. PMID 19276344 DOI: 10.1158/0008-5472.Can-08-4312 |
0.621 |
|
| 2009 |
Wang Z, Kong D, Li Y, Sarkar FH. PDGF-D signaling: a novel target in cancer therapy. Current Drug Targets. 10: 38-41. PMID 19149534 DOI: 10.2174/138945009787122914 |
0.582 |
|
| 2009 |
Chinnakannu K, Chen D, Li Y, Wang Z, Dou QP, Reddy GP, Sarkar FH. Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells. Journal of Cellular Physiology. 219: 94-9. PMID 19062173 DOI: 10.1002/Jcp.21650 |
0.608 |
|
| 2009 |
Wang Z, Li Y, Banerjee S, Sarkar FH. Emerging role of Notch in stem cells and cancer. Cancer Letters. 279: 8-12. PMID 19022563 DOI: 10.1016/J.Canlet.2008.09.030 |
0.606 |
|
| 2009 |
Ahmad A, Banerjee S, Wang Z, Kong D, Sarkar FH. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2. Journal of Cellular Biochemistry. 105: 1461-71. PMID 18980240 DOI: 10.1002/Jcb.21966 |
0.594 |
|
| 2008 |
Kaseb AO, Banerjee S, Wang Z, Sarkar FH, Ramzi M. Enhanced chemosensitivity to gemcitabine and oxaliplatin by thymoquinone in pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 15565. PMID 27947380 DOI: 10.1200/Jco.2008.26.15_Suppl.15565 |
0.602 |
|
| 2008 |
Wang Z, Li Y, Banerjee S, Sarkar FH. Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Research. 28: 3621-30. PMID 19189643 |
0.494 |
|
| 2008 |
Sarkar FH, Li Y, Wang Z, Kong D. NF-kappaB signaling pathway and its therapeutic implications in human diseases. International Reviews of Immunology. 27: 293-319. PMID 18853341 DOI: 10.1080/08830180802276179 |
0.571 |
|
| 2008 |
Azmi AS, Wang Z, Burikhanov R, Rangnekar VM, Wang G, Chen J, Wang S, Sarkar FH, Mohammad RM. Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis. Molecular Cancer Therapeutics. 7: 2884-93. PMID 18790769 DOI: 10.1158/1535-7163.Mct-08-0438 |
0.61 |
|
| 2008 |
Li Y, Wang Z, Kong D, Li R, Sarkar SH, Sarkar FH. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. The Journal of Biological Chemistry. 283: 27707-16. PMID 18687691 DOI: 10.1074/Jbc.M802759200 |
0.567 |
|
| 2008 |
Wang Z, Desmoulin S, Banerjee S, Kong D, Li Y, Deraniyagala RL, Abbruzzese J, Sarkar FH. Synergistic effects of multiple natural products in pancreatic cancer cells. Life Sciences. 83: 293-300. PMID 18640131 DOI: 10.1016/J.Lfs.2008.06.017 |
0.606 |
|
| 2008 |
Wang Z, Song W, Aboukameel A, Mohammad M, Wang G, Banerjee S, Kong D, Wang S, Sarkar FH, Mohammad RM. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer. International Journal of Cancer. Journal International Du Cancer. 123: 958-66. PMID 18528859 DOI: 10.1002/Ijc.23610 |
0.667 |
|
| 2008 |
Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Letters. 269: 226-42. PMID 18492603 DOI: 10.1016/J.Canlet.2008.03.052 |
0.669 |
|
| 2008 |
Kong D, Wang Z, Sarkar SH, Li Y, Banerjee S, Saliganan A, Kim HR, Cher ML, Sarkar FH. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells (Dayton, Ohio). 26: 1425-35. PMID 18403754 DOI: 10.1634/Stemcells.2007-1076 |
0.628 |
|
| 2008 |
Kong D, Banerjee S, Huang W, Li Y, Wang Z, Kim HR, Sarkar FH. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. Cancer Research. 68: 1927-34. PMID 18339874 DOI: 10.1158/0008-5472.Can-07-3241 |
0.566 |
|
| 2008 |
Banerjee S, Wang Z, Mohammad M, Sarkar FH, Mohammad RM. Efficacy of selected natural products as therapeutic agents against cancer. Journal of Natural Products. 71: 492-6. PMID 18302335 DOI: 10.1021/Np0705716 |
0.488 |
|
| 2008 |
Wang Z, Yu BW, Rahman KM, Ahmad F, Sarkar FH. Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip. Molecular Cancer Therapeutics. 7: 341-9. PMID 18281517 DOI: 10.1158/1535-7163.Mct-07-0476 |
0.593 |
|
| 2008 |
Wang Z, Kong D, Banerjee S, Li Y, Adsay NV, Abbruzzese J, Sarkar FH. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Cancer Research. 67: 11377-85. PMID 18056465 DOI: 10.1158/0008-5472.Can-07-2803 |
0.539 |
|
| 2008 |
Wang Z, Azmi AS, Banerjee S, Aboukameel A, Wang S, Sarkar FH, Mohammad RM. TW-37 INHIBITS CELL GROWTH AND INDUCES APOPTOSIS IN PANCREATIC CANCER Pancreas. 37: 500. DOI: 10.1097/01.Mpa.0000335408.77670.4A |
0.613 |
|
| 2008 |
Banerjee S, Kaseb A, Wang Z, Kong D, Padhaye S, Mohammad R, Sarkar FH. IN VIVO MOLECULAR EVIDENCE FOR ENHANCED CHEMOSENSITIVITY OF PANCREATIC CANCER CELLS TO GEMCITABINE AND OXALIPLATIN BY THYMOQUINONE Pancreas. 37: 461. DOI: 10.1097/01.Mpa.0000335341.28085.C8 |
0.611 |
|
| 2007 |
Rahman KMW, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, Sakr WA, Raz A. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Molecular Cancer Therapeutics. 6: 2757-2765. PMID 17913854 DOI: 10.1158/1535-7163.Mct-07-0336 |
0.524 |
|
| 2007 |
Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Research. 67: 8293-300. PMID 17804744 DOI: 10.1158/0008-5472.Can-07-1265 |
0.626 |
|
| 2007 |
Ambike V, Adsule S, Ahmed F, Wang Z, Afrasiabi Z, Sinn E, Sarkar F, Padhye S. Copper conjugates of nimesulide Schiff bases targeting VEGF, COX and Bcl-2 in pancreatic cancer cells. Journal of Inorganic Biochemistry. 101: 1517-24. PMID 17689613 DOI: 10.1016/J.Jinorgbio.2007.06.028 |
0.538 |
|
| 2007 |
Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GP, Sarkar FH. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. The Journal of Biological Chemistry. 282: 21542-50. PMID 17522055 DOI: 10.1074/Jbc.M701978200 |
0.553 |
|
| 2007 |
Banerjee S, Hussain M, Wang Z, Saliganan A, Che M, Bonfil D, Cher M, Sarkar FH. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer. Cancer Research. 67: 3818-26. PMID 17440096 DOI: 10.1158/0008-5472.Can-06-3879 |
0.586 |
|
| 2007 |
Kong D, Li Y, Wang Z, Banerjee S, Sarkar FH. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Research. 67: 3310-9. PMID 17409440 DOI: 10.1158/0008-5472.Can-06-4277 |
0.577 |
|
| 2007 |
Banerjee S, Zhang Y, Wang Z, Che M, Chiao PJ, Abbruzzese JL, Sarkar FH. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. International Journal of Cancer. 120: 906-17. PMID 17131310 DOI: 10.1002/Ijc.22332 |
0.653 |
|
| 2007 |
Rahman KM, Sarkar FH, Banerjee S, Wang Z, Liao DJ, Hong X, Sarkar NH. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Molecular Cancer Therapeutics. 5: 2747-56. PMID 17121921 DOI: 10.1158/1535-7163.Mct-06-0221 |
0.568 |
|
| 2007 |
Wang Z, Song W, Aboukameel A, Wang G, Wang S, Sarkar FH, Mohammad RM. TW-37, A NONPEPTIDIC SMALL-MOLECULE INHIBITOR OF BCL-2, INHIBITS INVASION AND ANGIOGENESIS IN PANCREATIC CANCER Pancreas. 35: 434-435. DOI: 10.1097/01.Mpa.0000297810.50526.D6 |
0.569 |
|
| 2007 |
Wang Z, Kong D, Banerjee S, Li Y, Sarkar FH. DOWN-REGULATION OF PDGF-D INHIBITS CELL GROWTH AND ANGIOGENESIS THROUGH INACTIVATION OF NOTCH-1 AND NF-κB SIGNALING Pancreas. 35: 434. DOI: 10.1097/01.Mpa.0000297809.34035.22 |
0.543 |
|
| 2007 |
Sarkar F, Banerjee S, Wang Z, Li Y, Abbruzzese J. A NOVEL NON-TOXIC MULTI-TARGETED APPROACH FOR PANCREATIC CANCER THERAPY Pancreas. 35: 425. DOI: 10.1097/01.Mpa.0000297777.10272.13 |
0.534 |
|
| 2007 |
Banerjee S, Wang Z, Kong D, Sarkar FH. IN VIVO MOLECULAR EVIDENCE OF CHEMOSENSITIZATION BY 3,3-DIINDOLYLMETHANE AGAINST PANCREATIC TUMOR Pancreas. 35: 393. DOI: 10.1097/01.Mpa.0000297666.91040.B8 |
0.491 |
|
| 2006 |
Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Research. 66: 10064-72. PMID 17047070 DOI: 10.1158/0008-5472.Can-06-2011 |
0.586 |
|
| 2006 |
Wang Z, Sengupta R, Banerjee S, Li Y, Zhang Y, Rahman KM, Aboukameel A, Mohammad R, Majumdar AP, Abbruzzese JL, Sarkar FH. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer. Cancer Research. 66: 7653-60. PMID 16885366 DOI: 10.1158/0008-5472.Can-06-1019 |
0.65 |
|
| 2006 |
Zhang Y, Wang Z, Ahmed F, Banerjee S, Li Y, Sarkar FH. Down-regulation of Jagged-1 induces cell growth inhibition and S phase arrest in prostate cancer cells. International Journal of Cancer. 119: 2071-7. PMID 16823852 DOI: 10.1002/Ijc.22077 |
0.598 |
|
| 2006 |
Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Cancer Research. 66: 4952-60. PMID 16651453 DOI: 10.1158/0008-5472.Can-05-3918 |
0.638 |
|
| 2006 |
Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer. 106: 2503-13. PMID 16628653 DOI: 10.1002/Cncr.21904 |
0.61 |
|
| 2006 |
Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Molecular Cancer Therapeutics. 5: 483-93. PMID 16546962 DOI: 10.1158/1535-7163.Mct-05-0299 |
0.669 |
|
| 2006 |
Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y, Sarkar FH. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Research. 66: 2778-84. PMID 16510599 DOI: 10.1158/0008-5472.Can-05-4281 |
0.564 |
|
| 2006 |
Zhang Y, Banerjee S, Wang Z, Xu H, Zhang L, Mohammad R, Aboukameel A, Adsay NV, Che M, Abbruzzese JL, Majumdar AP, Sarkar FH. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. Cancer Research. 66: 1025-32. PMID 16424038 DOI: 10.1158/0008-5472.Can-05-2968 |
0.595 |
|
| 2006 |
Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. International Journal of Cancer. 118: 1930-6. PMID 16284950 DOI: 10.1002/Ijc.21589 |
0.66 |
|
| 2006 |
Banerjee S, Wang Z, Chaio PJ, Sarkar FH. MOLECULAR EVIDENCE OF 3,3???-DIINDOLYLMETHANE INDUCED ENHANCEMENT IN CHEMOSENSITIVITY OF PANCREATIC CANCER CELLS TO MULTIPLE CHEMOTHERAPEUTIC AGENTS Pancreas. 33: 445. DOI: 10.1097/00006676-200611000-00035 |
0.61 |
|
| 2005 |
Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Research. 65: 9064-72. PMID 16204081 DOI: 10.1158/0008-5472.Can-05-1330 |
0.656 |
|
| 2005 |
Zhang Y, Banerjee S, Wang ZW, Marciniak DJ, Majumdar AP, Sarkar FH. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells. Cancer Research. 65: 3877-82. PMID 15867387 DOI: 10.1158/0008-5472.Can-04-3654 |
0.602 |
|
| 2005 |
Wang Z, Zhang Y, Banerjee S, Sarkar FH. INHIBITION OF NUCLEAR FACTOR ??B ACTIVATION IN BXPC-3 CELLS BY GENISTEIN IS MEDIATED VIA NOTCH-1 SIGNALING PATHWAY Pancreas. 31: 478. DOI: 10.1097/01.Mpa.0000193794.36379.60 |
0.523 |
|
| 2005 |
Banerjee S, Zhang Y, Wang Z, Bhuiyan M, Chiao PJ, Sarkar FH. IN VIVO MOLECULAR EVIDENCE ON CHEMOSENSITIZATION OF PANCREATIC TUMOR BY GENISTEIN Pancreas. 31: 432-433. DOI: 10.1097/01.Mpa.0000193638.18935.8D |
0.492 |
|
| Show low-probability matches. |